Galleri Multi-Cancer Screening Available to Curative Members
Putting our members' health first and embracing the power of proactive health screenings, Curative is proud to offer eligible members no-cost access to the Galleri® multi-cancer early detection test from GRAIL. Galleri is the first-of-its-kind — a test that looks for a signal shared by more than 50 types of cancer with a single blood test. Further testing is required to diagnose cancer.
Who is eligible?
Active Curative plan members residing in the United States who have also completed their annual Baseline Visit
Aged 50 years old and older
Not currently pregnant
Not currently undergoing active cancer treatment, though history of cancer* with treatments completed at least 5 years ago is permitted
Learn more about the Galleri test
Questions or concerns on the test? Please contact your Care Navigator or member support health@curative.com.
Curative Testing Process
How do I take the test?
How do I take the test?
Complete your Curative Baseline Visit
Meet with your Care Navigator and a Curative Clinician for an individualized, preventive care plan and ensure you receive no copays and no deductibles for in-network care.
Request the test
After your Baseline Visit is completed, visit galleri.com/curative to request the test from an independent telemedicine provider.
You will create a Galleri portal account and complete an online test request which includes questions about your medical history (about 10 minutes). The telemedicine provider will review your request.
Receive a collection kit and provide your sample
If the telemedicine provider confirms you're eligible and that Galleri is appropriate for you, they will order the test.
You can schedule a blood draw at a GRAIL blood draw partner and we will ship you a Galleri collection kit for your appointment. The trained technician that draws your blood sample will ship the kit back to the GRAIL lab.
Receive your results
The ordering telemedicine provider will share your test result when ready — about 2 weeks after your blood draw sample arrives at the GRAIL lab.
Important Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / Test Information
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.